GFAP and COVID-19: Finally, positive correlations between the CSF and plasma levels of NfL and GFAP in COVID-19 patients with severe NS on hospital admission, validate their plasma assessment as a less-invasive biomarker for diagnosis, prognosis and monitoring of CNS damage associated with COVID-19.